134 related articles for article (PubMed ID: 25112672)
1. Diffusion-weighted MR imaging findings in a growing problem: hepatic alveolar echinococcosis.
Kantarci M; Pirimoglu B
Eur J Radiol; 2014 Oct; 83(10):1991-2. PubMed ID: 25112672
[TBL] [Abstract][Full Text] [Related]
2. Alveolar echinococcosis of the liver: diffusion-weighted MRI findings and potential role in lesion characterisation.
Becce F; Pomoni A; Uldry E; Halkic N; Yan P; Meuli R; Schmidt S
Eur J Radiol; 2014 Apr; 83(4):625-31. PubMed ID: 24457140
[TBL] [Abstract][Full Text] [Related]
3. Differentiation between hepatic alveolar echinococcosis and primary hepatic malignancy with diffusion-weighted magnetic resonance imaging.
Sade R; Kantarci M; Ogul H; Gundogdu B; Aydınlı B
Diagn Interv Imaging; 2018 Mar; 99(3):169-177. PubMed ID: 29110943
[TBL] [Abstract][Full Text] [Related]
4. Response to "diffusion-weighted MR imaging findings in a growing problem: hepatic alveolar echinococcosis".
Schmidt S; Becce F
Eur J Radiol; 2014 Oct; 83(10):1993-4. PubMed ID: 25112670
[No Abstract] [Full Text] [Related]
5. Differential diagnosis of benign and malignant breast masses using diffusion-weighted magnetic resonance imaging.
Min Q; Shao K; Zhai L; Liu W; Zhu C; Yuan L; Yang J
World J Surg Oncol; 2015 Feb; 13():32. PubMed ID: 25889380
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of malignant from benign focal splenic lesions: added value of diffusion-weighted MRI.
Jang KM; Kim SH; Hwang J; Lee SJ; Kang TW; Lee MW; Choi D
AJR Am J Roentgenol; 2014 Oct; 203(4):803-12. PubMed ID: 25247945
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma.
Vandecaveye V; De Keyzer F; Verslype C; Op de Beeck K; Komuta M; Topal B; Roebben I; Bielen D; Roskams T; Nevens F; Dymarkowski S
Eur Radiol; 2009 Oct; 19(10):2456-66. PubMed ID: 19440718
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted imaging of the liver: optimizing b value for the detection and characterization of benign and malignant hepatic lesions.
Goshima S; Kanematsu M; Kondo H; Yokoyama R; Kajita K; Tsuge Y; Watanabe H; Shiratori Y; Onozuka M; Moriyama N
J Magn Reson Imaging; 2008 Sep; 28(3):691-7. PubMed ID: 18777553
[TBL] [Abstract][Full Text] [Related]
9. Value of apparent diffusion coefficient measurement for discrimination of focal benign and malignant hepatic masses.
Kilickesmez O; Bayramoglu S; Inci E; Cimilli T
J Med Imaging Radiat Oncol; 2009 Feb; 53(1):50-5. PubMed ID: 19453528
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging.
Catalano OA; Choy G; Zhu A; Hahn PF; Sahani DV
Radiology; 2010 Jan; 254(1):154-62. PubMed ID: 20032150
[TBL] [Abstract][Full Text] [Related]
11. High-b-value diffusion-weighted MR imaging of benign hepatocellular lesions: quantitative and qualitative analysis.
Agnello F; Ronot M; Valla DC; Sinkus R; Van Beers BE; Vilgrain V
Radiology; 2012 Feb; 262(2):511-9. PubMed ID: 22143926
[TBL] [Abstract][Full Text] [Related]
12. Solid focal liver lesion characterisation with apparent diffusion coefficient ratios.
Sutherland T; Steele E; van Tonder F; Yap K
J Med Imaging Radiat Oncol; 2014 Feb; 58(1):32-7. PubMed ID: 24529053
[TBL] [Abstract][Full Text] [Related]
13. Diffusion kurtosis imaging of the liver at 3 Tesla: in vivo comparison to standard diffusion-weighted imaging.
Budjan J; Sauter EA; Zoellner FG; Lemke A; Wambsganss J; Schoenberg SO; Attenberger UI
Acta Radiol; 2018 Jan; 59(1):18-25. PubMed ID: 28454487
[TBL] [Abstract][Full Text] [Related]
14. Utility and limitations of 3-Tesla diffusion-weighted magnetic resonance imaging for differentiation of renal tumors.
Sevcenco S; Heinz-Peer G; Ponhold L; Javor D; Kuehhas FE; Klingler HC; Remzi M; Weibl P; Shariat SF; Baltzer PA
Eur J Radiol; 2014 Jun; 83(6):909-913. PubMed ID: 24709332
[TBL] [Abstract][Full Text] [Related]
15. Malignant hepatic tumors: short-term reproducibility of apparent diffusion coefficients with breath-hold and respiratory-triggered diffusion-weighted MR imaging.
Kim SY; Lee SS; Byun JH; Park SH; Kim JK; Park B; Kim N; Lee MG
Radiology; 2010 Jun; 255(3):815-23. PubMed ID: 20501719
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted MRI and optimal b-value for characterization of liver lesions.
Kaya B; Koc Z
Acta Radiol; 2014 Jun; 55(5):532-42. PubMed ID: 23982322
[TBL] [Abstract][Full Text] [Related]
17. Small hyperintense hepatic lesions on T1-weighted images in patients with cirrhosis: evaluation with serial MRI and imaging features for clinical benignity.
Shimizu A; Ito K; Sasaki K; Hayashida M; Tanabe M; Shimizu K; Matsunaga N
Magn Reson Imaging; 2007 Dec; 25(10):1430-6. PubMed ID: 17524587
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Liver Tumors by Diffusion-Weighted Imaging: Comparison of Diagnostic Performance Using the Mean and Minimum Apparent Diffusion Coefficient.
Namimoto T; Nakagawa M; Kizaki Y; Itatani R; Kidoh M; Utsunomiya D; Oda S; Yamashita Y
J Comput Assist Tomogr; 2015; 39(4):453-61. PubMed ID: 25836022
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted magnetic resonance imaging for characterization of focal liver masses: impact of parallel imaging (SENSE) and b value.
Erturk SM; Ichikawa T; Sano K; Motosugi U; Sou H; Araki T
J Comput Assist Tomogr; 2008; 32(6):865-71. PubMed ID: 19204445
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted MRI of the liver-Interpretative pearls and pitfalls.
Culverwell AD; Sheridan MB; Guthrie JA; Scarsbrook AF
Clin Radiol; 2013 Apr; 68(4):406-14. PubMed ID: 22981728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]